- Home
- Publications
- Publication Search
- Publication Details
Title
Protein engineering to target complement evasion in cancer
Authors
Keywords
-
Journal
FEBS LETTERS
Volume 588, Issue 2, Pages 334-340
Publisher
Wiley
Online
2013-11-14
DOI
10.1016/j.febslet.2013.11.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional Anatomy of Complement Factor H
- (2013) Elisavet Makou et al. BIOCHEMISTRY
- Expression of recombinant human complement C1q allows identification of the C1r/C1s-binding sites
- (2013) I. Bally et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Humoral Pattern Recognition and the Complement System
- (2013) S. E. Degn et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Characterization of novel CD55 isoforms expression in normal and neoplastic tissues
- (2013) E. D. Vainer et al. TISSUE ANTIGENS
- Structural Basis for Recognition of the Pore-Forming Toxin Intermedilysin by Human Complement Receptor CD59
- (2013) Steven Johnson et al. Cell Reports
- Removal of the Tag from His-tagged ILYd4, a Human CD59 Inhibitor, Significantly Improves its Physical Properties and its Activity
- (2012) Lin Wu et al. CURRENT PHARMACEUTICAL DESIGN
- Regulation of Humoral Immunity by Complement
- (2012) Michael C. Carroll et al. IMMUNITY
- HER2/neu as a Potential Target for Immunotherapy in Gynecologic Carcinosarcomas
- (2012) Federica Guzzo et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Arranged Sevenfold: Structural Insights into the C-Terminal Oligomerization Domain of Human C4b-Binding Protein
- (2012) Thomas Hofmeyer et al. JOURNAL OF MOLECULAR BIOLOGY
- Transient Removal of CD46 Is Safe and Increases B-cell Depletion by Rituximab in CD46 Transgenic Mice and Macaques
- (2012) Ines Beyer et al. MOLECULAR THERAPY
- Complement in health and disease
- (2011) Maria V. Carroll et al. ADVANCED DRUG DELIVERY REVIEWS
- Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for Treatment of Refractory Chronic Lymphocytic Leukemia
- (2011) Ginah Nightingale ANNALS OF PHARMACOTHERAPY
- Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis
- (2011) W. Hu et al. CANCER RESEARCH
- Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor
- (2011) Emiliano Cocco et al. CLINICAL & EXPERIMENTAL METASTASIS
- Trastuzumab Treatment in Multiple Lines: Current Data and Future Directions
- (2011) M. Pegram et al. Clinical Breast Cancer
- rILYd4, a Human CD59 Inhibitor, Enhances Complement-Dependent Cytotoxicity of Ofatumumab against Rituximab-Resistant B-cell Lymphoma Cells and Chronic Lymphocytic Leukemia
- (2011) X. Ge et al. CLINICAL CANCER RESEARCH
- Vitronectin dictates intraglomerular fibrinolysis in immune-mediated glomerulonephritis
- (2011) Laurent Mesnard et al. FASEB JOURNAL
- CD46 processing: A means of expression
- (2011) Siobhan Ni Choileain et al. IMMUNOBIOLOGY
- Complement factor I in health and disease
- (2011) Sara C. Nilsson et al. MOLECULAR IMMUNOLOGY
- C1-Inhibitor: More Than a Serine Protease Inhibitor
- (2011) Sacha Zeerleder SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack In Vitro
- (2010) N. Geis et al. CURRENT CANCER DRUG TARGETS
- Jmol– a paradigm shift in crystallographic visualization
- (2010) Robert M. Hanson JOURNAL OF APPLIED CRYSTALLOGRAPHY
- Ofatumumab
- (2010) Bodi Zhang mAbs
- Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions
- (2010) Gregory L. Moore et al. mAbs
- Role and mechanism of action of complement in regulating T cell immunity
- (2010) Jason R. Dunkelberger et al. MOLECULAR IMMUNOLOGY
- Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells
- (2010) John Cardone et al. NATURE IMMUNOLOGY
- Complement: a key system for immune surveillance and homeostasis
- (2010) Daniel Ricklin et al. NATURE IMMUNOLOGY
- A recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapy
- (2009) H. Wang et al. BLOOD
- Complement and its role in innate and adaptive immune responses
- (2009) Jason R Dunkelberger et al. CELL RESEARCH
- Optimization of Fc-mediated effector functions of monoclonal antibodies
- (2009) William R Strohl CURRENT OPINION IN BIOTECHNOLOGY
- The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1/CD35)
- (2009) Dong Liu et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- A High-Affinity Inhibitor of Human CD59 Enhances Complement-Mediated Virolysis of HIV-1: Implications for Treatment of HIV-1/AIDS
- (2009) Weiguo Hu et al. JOURNAL OF IMMUNOLOGY
- CD59 Blockade Enhances Antigen-Specific CD4+ T Cell Responses in Humans: A New Target for Cancer Immunotherapy?
- (2009) B. Sivasankar et al. JOURNAL OF IMMUNOLOGY
- Expression of complement regulatory proteins: CD46, CD55, and CD59 and response to rituximab in patients with CD20(+) non-Hodgkin’s lymphoma
- (2009) Justyna Dzietczenia et al. MEDICAL ONCOLOGY
- Upregulated expression of complement inhibitory proteins on bladder cancer cells and anti‐MUC1 antibody immune selection
- (2008) Juan Carlos Varela et al. INTERNATIONAL JOURNAL OF CANCER
- In Vitro and In Vivo Properties of Adenovirus Vectors with Increased Affinity to CD46
- (2008) H. Wang et al. JOURNAL OF VIROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started